CUSIP: 89853L104
Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
14,015,351
-
Share change
-
+70,817
-
Total reported value
-
$122,775,460
-
Price per share
-
$8.76
-
Number of holders
-
51
-
Value change
-
-$3,878,117
-
Number of buys
-
26
-
Number of sells
-
26
Quarterly Holders Quick Answers
What is CUSIP 89853L104?
CUSIP 89853L104 identifies TTOO - T2 BIOSYSTEMS INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q4 2015
-
Previous quarter:
Q2 2015
Recent filing periods for CUSIP 89853L104:
Institutional Holders of T2 BIOSYSTEMS INC - COM (TTOO) as of Q3 2015
As of 30 Sep 2015,
T2 BIOSYSTEMS INC - COM (TTOO) was held by
51 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
14,015,351 shares.
The largest 10 holders included
GOLDMAN SACHS GROUP INC, Aisling Capital LLC, Polaris Venture Management Co. V, L.L.C., GILDER GAGNON HOWE & CO LLC, WELLINGTON MANAGEMENT GROUP LLP, Senvest Management, LLC, Point72 Asset Management, L.P., PRICE T ROWE ASSOCIATES INC /MD/, VANGUARD GROUP INC, and ESSEX INVESTMENT MANAGEMENT CO LLC.
This page lists
51
institutional shareholders reporting positions in this security
for the Q3 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.